Before The Freeze: US FDA Inspection Data Pointed To Continued Foreign Facility Focus
Until the coronavirus forced it to stop, the FDA had planned to up domestic and foreign inspections in FY 2020 and FY 2021, as the longer-term trend showed domestic inspections dropping and foreign inspections rising.
You may also be interested in...
President Trump's budget request would boost compounding and vaccines by $5m, but human drugs program would lose $4.8m in training funds.
Now that US FDA has approved the final EU authority, mutual recognition efforts could expand and deepen. Former FDA chief counsel Rebecca Wood discusses the future of approval standards harmonization in Pink Sheet interview.
FDA will have completed capability assessments for eight European Union member country inspectorates by that time, with all 28 to be completed by mid-2019; EU assessment of US regulator’s inspection capabilities wraps up in July.